全身靜脈內(nèi)過繼轉(zhuǎn)移自體淋巴因子激活αβT細胞改
Systemic Intravenous Adoptive Transfer of Autologous Lymphokine-activated T-Cells Improves Temozolomide-induced Lymphopenia in Patients with Glioma Kanemura Y1,2, Sumida M3, Okita Y2, Yoshioka E4, Yamamoto A4, Kanematsu D3, Handa Y3, Fukusu...
過繼免疫化療聯(lián)合化療治療IV期結(jié)直腸癌的臨床研
Clinical Study on the Medical Value of Combination Therapy Involving Adoptive Immunotherapy and Chemotherapy for Stage IV Colorectal Cancer (COMVI Study) Yoshida Y1, Naito M2, Yamada T2, Aisu N2, Kojima D2, Mera T2, Tanaka T3, Naito K4, Yas...
過繼性免疫細胞治療晚期胃癌的療效：回顧性研
Efficacy of Adoptive Immune-cell Therapy in Patients with Advanced Gastric Cancer: A Retrospective Study Takimoto R1, Kamigaki T2, Okada S2, Matsuda E2, Ibe H2, Oguma E2, Naitoh K2, Makita K2, Goto S2 Anticancer Res. 2017 Jul;37(7):3947-395...
使用活化的αβT細胞進行過度化學(xué)免疫治療后結(jié)直
Hepatectomy for Liver Metastases of Colorectal Cancer After Adoptive Chemoimmunotherapy Using Activated T-cells Ishii F1, Yoshida Y2, Yamauchi Y1, Aisu N1, Kojima D1, Mera T1, Kato D1, Tanaka T3, Naito K4, Yasumoto K4, Kamigaki T4, Goto S4,...
通過mRNA-EP制備的腫瘤血管靶向CAR-T細胞的免疫學(xué)
Immunological quality and performance of tumor vessel-targeting CAR-T cells prepared by mRNA-EP for clinical research. Inoo K1, Inagaki R1, Fujiwara K1, Sasawatari S2, Kamigaki T3, Nakagawa S1, Okada N1. Mol Ther Oncolytics. 2016 Nov 16;3:1...
采用活化αβT細胞過繼化學(xué)免疫治療Ⅳ期結(jié)直腸癌
Adoptive Chemoimmunotherapy Using Activated T Cells for Stage IV Colorectal Cancer. Yoshida Y1, Naito M2, Yamada T2, Aisu N2, Daibo K2, Mera T2, Tanaka T3, Naito K4, Yasumoto K4, Kamigaki T4, Goto S4, Yamashita Y2, Hasegawa S2 Anticancer Re...
各種實體癌細胞WT1抗原表達的免疫組化分析
Immunohistochemical Analysis of WT1 Antigen Expression in Various Solid Cancer Cells Naitoh K1, Kamigaki T2, Matsuda E2, Ibe H2, Okada S2, Oguma E2, Kinoshita Y2, Takimoto R2, Makita K2, Ogasawara S2, Goto S2. Anticancer Res. 2016 Jul;36(7)...
自體免疫細胞療法改善各種晚期癌癥患者免疫狀
Improvement of Impaired Immunological Status of Patients with Various Types of Advanced Cancers by Autologous Immune Cell Therapy Kamigaki T1, Ibe H2, Okada S2, Matsuda E2, Tanaka M2, Oguma E2, Kinoshita Y2, Ogasawara S2, Ono A2, Makita K2,...
前瞻性評估各類晚期癌癥患者免疫細胞治療的安
Prospective Evaluation of Safety of Immune-cell Therapy for Patients with Various Types of Advanced Cancer Kamigaki T1, Matsuda E2, Okada S2, Naitoh K2, Kondo T3, Ibe H2, Maekawa R3, Goto S2. Anticancer Res. 2014 Aug;34(8):4601-7. Abstract...